VSTM Verastem, Inc.
Healthcare$4.30+0.00%OpenMarket Cap: $297.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.10
P/S
5.93
EV/EBITDA
-1.02
DCF Value
$-4.17
FCF Yield
-51.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
83.7%
Operating Margin
-344.6%
Net Margin
-391.2%
ROE
-486.4%
ROA
-85.1%
ROIC
-102.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $18.7M | 83.7% | $-44.9M | $-36.6M | $— | — |
| Q4 null | $17.5M | 83.5% | $-41.5M | $-32.9M | $— | — |
| FY null | $30.9M | 82.9% | $-170.1M | $-209.5M | $— | — |
| Q3 null | $11.2M | 85.1% | $-40.7M | $-98.5M | $— | — |
| Q2 null | $2.1M | 79.1% | $-43.8M | $-25.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-44.2M | $-52.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-31.6M | $-64.6M | $— | — |
| FY null | $10.0M | 100.0% | $-115.0M | $-130.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-37.0M | $-24.0M | $— | — |
| Q2 null | $10.0M | 100.0% | $-18.3M | $-8.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-28.1M | $-33.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-31.1M | $-27.4M | $-1.02 | — |